| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.191 | 10.105 | 6.448 | 6.232 | 6.968 | 8.222 | 7.303 | 9.200 | 13.034 | 21.079 |
| Total Income - EUR | 4.191 | 10.105 | 6.448 | 6.232 | 6.968 | 8.290 | 7.303 | 9.200 | 13.034 | 21.079 |
| Total Expenses - EUR | 1.565 | 4.882 | 4.264 | 663 | 1.136 | 1.003 | 1.057 | 2.477 | 1.762 | 9.867 |
| Gross Profit/Loss - EUR | 2.626 | 5.223 | 2.184 | 5.569 | 5.832 | 7.287 | 6.245 | 6.723 | 11.273 | 11.212 |
| Net Profit/Loss - EUR | 2.500 | 4.920 | 1.991 | 5.382 | 5.623 | 7.041 | 6.052 | 6.461 | 9.662 | 9.454 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Aldorado Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 67 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38 |
| Current Assets | 2.756 | 6.280 | 2.494 | 7.517 | 10.044 | 13.098 | 18.394 | 12.734 | 13.307 | 20.432 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 109 | 96 | 96 | 93 | 33 | 12 | 55 | 91 | 56 |
| Cash | 2.756 | 6.171 | 2.398 | 7.421 | 9.951 | 13.065 | 18.382 | 12.680 | 13.215 | 20.375 |
| Shareholders Funds | 2.545 | 4.973 | 2.043 | 7.388 | 5.673 | 12.606 | 18.379 | 12.581 | 12.457 | 11.189 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 278 | 1.307 | 451 | 129 | 4.371 | 492 | 15 | 154 | 905 | 9.316 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Aldorado Medical Srl